0 Process

\(\text{Table}\:\text{1.}\) Robot vs LPS+LESS
Robot LPS+LESS
Segmental 26 13 39
NxUx 456 1531 1987
LESS 0 7 7
482 1551 2033


0.1 variable/value

  • BMI group (Normal/Overweight) replaces height and weight.
  • Keep 1, 5, and 6 (other) from cell type.
  • Simple claster for tumor position.
  • Split tumor size at 2 cm.
  • stage 0a and stage 0is as same stage.
  • G2 as high grade.
  • Some of eGFR before and after the surgery are infinity, I then give 240 month (20 years) as the value.
\(\text{Table}\:\text{2.}\) Robot vs LPS+LESS after cleaning
Robot LPS+LESS
N 479 1545 2024



1 Baseline

With NA

Patient’s Baseline Characteristics
level 1 ROBOT 2 LPS+LESS p test SMD
n 479 1545
ECOG (%) 0 無症狀 248 (51.8) 609 (39.4) <0.001 0.521
1 有症狀,可步行對生活不影響 187 (39.0) 536 (34.7)
2 躺在床上時間小於50% 22 ( 4.6) 83 ( 5.4)
3 躺在床上時間大於50% 3 ( 0.6) 9 ( 0.6)
4 完全臥床 0 ( 0.0) 4 ( 0.3)
NA 19 ( 4.0) 304 (19.7)
性別 (%) 1 男 202 (42.2) 636 (41.2) 0.736 0.020
2 女 277 (57.8) 909 (58.8)
BMI (%) Normal 228 (47.6) 582 (37.7) <0.001 0.321
Overweight 133 (27.8) 354 (22.9)
NA 118 (24.6) 609 (39.4)
Cell_Type (%) 1 urothelial 414 (86.4) 1390 (90.0) 0.090 0.111
5 UC with variants (Squamous cell, glandular, sarcomatous, micro papillary, neuroendocrine, lymphoepithelial) 61 (12.7) 147 ( 9.5)
6 others 4 ( 0.8) 8 ( 0.5)
左右側 (%) 1 左 249 (52.0) 802 (51.9) 0.990 0.008
2 右 223 (46.6) 719 (46.5)
3 雙側 7 ( 1.5) 24 ( 1.6)
腫瘤位置 (%) 0 non-visible 1 ( 0.2) 1 ( 0.1) 0.517 0.104
1 腎盂 186 (38.8) 655 (42.4)
2 輸尿管 175 (36.5) 500 (32.4)
3 膀胱袖口 1 ( 0.2) 2 ( 0.1)
4 多個位置 115 (24.0) 385 (24.9)
5 無法識別 1 ( 0.2) 2 ( 0.1)
多發性 (%) 0 Not available 19 ( 4.0) 92 ( 6.0) 0.246 0.092
1 No 295 (61.6) 936 (60.6)
2 Yes 165 (34.4) 517 (33.5)
腫瘤大小 (%) 0 Not available 7 ( 1.5) 56 ( 3.6) 0.050 0.141
1 <2cm 153 (31.9) 462 (29.9)
2 >=2cm 319 (66.6) 1027 (66.5)
病理分期 (%) 1 stage 0a/0is 73 (15.2) 241 (15.6) 0.018 0.185
2 stage I 118 (24.6) 436 (28.2)
3 stage II 79 (16.5) 296 (19.2)
4 stage III 144 (30.1) 442 (28.6)
5 stage IV 52 (10.9) 106 ( 6.9)
NA 13 ( 2.7) 24 ( 1.6)
完整檢體腫瘤惡性度 (%) 1 papillary urothelial neoplasm of low malignant potential 1 ( 0.2) 1 ( 0.1) 0.185 0.124
2 low grade 47 ( 9.8) 140 ( 9.1)
3 high grade 418 (87.3) 1372 (88.8)
4 Gx 2 ( 0.4) 15 ( 1.0)
NA 11 ( 2.3) 17 ( 1.1)
合併膀胱腫瘤 (%) 0 No 356 (74.3) 1078 (69.8) 0.096 0.159
1 Previous Hx of bladder UC 33 ( 6.9) 114 ( 7.4)
2 Concurrent Bladder UC 70 (14.6) 261 (16.9)
3 Not available 14 ( 2.9) 41 ( 2.7)
NA 6 ( 1.3) 51 ( 3.3)
合併CIS (%) 0 No 323 (67.4) 1060 (68.6) 0.062 0.133
1 Yes 149 (31.1) 434 (28.1)
NA 7 ( 1.5) 51 ( 3.3)
Lymphovascular_invasion (%) 0 No 366 (76.4) 1256 (81.3) <0.001 0.189
1 Yes 92 (19.2) 267 (17.3)
NA 21 ( 4.4) 22 ( 1.4)
surgical_margin (%) 0 free 449 (93.7) 1472 (95.3) 0.066 0.117
1 positive 26 ( 5.4) 51 ( 3.3)
NA 4 ( 0.8) 22 ( 1.4)
術前水腎 (%) 1 No 207 (43.2) 719 (46.5) 0.137 0.106
2 Yes 258 (53.9) 761 (49.3)
NA 14 ( 2.9) 65 ( 4.2)
Tumor_Necrosis (%) 0 No 412 (86.0) 1133 (73.3) <0.001 0.439
1 Yes 57 (11.9) 208 (13.5)
NA 10 ( 2.1) 204 (13.2)
有無針對UTUC化療 (%) 0 No 321 (67.0) 1075 (69.6) 0.018 0.155
1 Yes 148 (30.9) 404 (26.1)
2 Not available 10 ( 2.1) 66 ( 4.3)
針對UTUC化療型態 (%) 1 neo-adjuvant 20 ( 4.2) 42 ( 2.7) 0.008 0.176
2 adjuvant 92 (19.2) 297 (19.2)
3 salvage (curative intent) 13 ( 2.7) 15 ( 1.0)
4 palliative (S/S relieve) 23 ( 4.8) 52 ( 3.4)
NA 331 (69.1) 1139 (73.7)
化療處方 (%) 1 Gemcitabine & cisplatin 39 ( 8.1) 125 ( 8.1) 0.079 0.151
2 MVAC 10 ( 2.1) 11 ( 0.7)
3 Taxans-based 0 ( 0.0) 1 ( 0.1)
4 Carboplatin-based 49 (10.2) 141 ( 9.1)
5 others 45 ( 9.4) 117 ( 7.6)
NA 336 (70.1) 1150 (74.4)
Bladder_cuff_resection (%) 0 Not perform BCR 11 ( 2.3) 47 ( 3.0) <0.001 2.194
1 Open incision 92 (19.2) 1027 (66.5)
2 Transurethral incision 9 ( 1.9) 55 ( 3.6)
4 Laparoscopy 6 ( 1.3) 306 (19.8)
5 Robot assisted 321 (67.0) 5 ( 0.3)
NA 40 ( 8.4) 105 ( 6.8)
simultaneously_ipsilateral_adrenalectomy (%) 0 No 408 (85.2) 1205 (78.0) 0.001 0.202
1 Yes 26 ( 5.4) 95 ( 6.1)
NA 45 ( 9.4) 245 (15.9)
Post_operation_intravesical_CT_instillation (%) 1 No 356 (74.3) 1370 (88.7) <0.001 0.477
2 術中膀胱灌藥 41 ( 8.6) 6 ( 0.4)
3 術後膀胱灌藥 38 ( 7.9) 51 ( 3.3)
NA 44 ( 9.2) 118 ( 7.6)
Clavien_Dindo_classification (%) 0 No Complication 284 (59.3) 905 (58.6) 0.011 0.243
1 Grade I 78 (16.3) 175 (11.3)
2 Grade II 76 (15.9) 239 (15.5)
3 Grade IIIa 4 ( 0.8) 14 ( 0.9)
4 Grade IIIb 4 ( 0.8) 21 ( 1.4)
5 Grade IVa 3 ( 0.6) 16 ( 1.0)
6 Grade IVb 0 ( 0.0) 1 ( 0.1)
7 Grade V 3 ( 0.6) 6 ( 0.4)
NA 27 ( 5.6) 168 (10.9)
Disease_free (%) 0 No 107 (22.3) 258 (16.7) <0.001 0.238
1 Yes 317 (66.2) 1089 (70.5)
3 Segmental resection 後復發或轉移 11 ( 2.3) 6 ( 0.4)
4 Unknown 44 ( 9.2) 192 (12.4)
Mortality (%) 0 No 313 (65.3) 838 (54.2) <0.001 0.343
1 UTUC related 66 (13.8) 176 (11.4)
2 Non-UTUC related 44 ( 9.2) 232 (15.0)
3 死因不明 27 ( 5.6) 204 (13.2)
4 Surgery related 2 ( 0.4) 9 ( 0.6)
5 無法判斷生死 27 ( 5.6) 86 ( 5.6)
長期_Complication (%) ESRD 11 ( 2.3) 48 ( 3.1) 0.020 0.231
ESRD, ileus 0 ( 0.0) 3 ( 0.2)
ESRD, ureter stricture (手術患側) 0 ( 0.0) 1 ( 0.1)
ESRD, ventral hernia 1 ( 0.2) 1 ( 0.1)
ileus 6 ( 1.3) 12 ( 0.8)
ileus, ventral hernia 0 ( 0.0) 6 ( 0.4)
No Complication 426 (88.9) 1362 (88.2)
No Complication, ureter stricture (手術患側) 0 ( 0.0) 2 ( 0.1)
ureter stricture (手術患側) 13 ( 2.7) 11 ( 0.7)
ventral hernia 4 ( 0.8) 12 ( 0.8)
NA 18 ( 3.8) 87 ( 5.6)
Lost_follow_up (%) 0 No 419 (87.5) 1386 (89.7) 0.004 0.172
1 Yes 50 (10.4) 100 ( 6.5)
NA 10 ( 2.1) 59 ( 3.8)
術後住院天數_day (mean (SD)) 7.60 (4.16) 8.44 (5.67) 0.004 0.168
手術到死亡間隔時間_月 (mean (SD)) 24.10 (17.50) 38.73 (32.69) <0.001 0.558
Longest_follow_up_month_for_BDFS_DFS (mean (SD)) 31.35 (22.81) 39.23 (31.63) <0.001 0.286
診斷年紀 (mean (SD)) 69.29 (10.23) 68.74 (10.49) 0.309 0.054
性別參數 (mean (SD)) 0.58 (0.49) 0.59 (0.49) 0.757 0.016
術前eGFR_MDRD_ml_min_1_73m2 (mean (SD)) 59.81 (44.62) 55.12 (43.81) 0.042 0.106
Post_OP_1_month_eGFR (mean (SD)) 161.97 (98.04) 164.65 (97.89) 0.601 0.027

Without NA

Patient’s Baseline Characteristics
level 1 ROBOT 2 LPS+LESS p test SMD
n 479 1545
ECOG (%) 0 無症狀 248 (53.9) 609 (49.1) 0.235 0.138
1 有症狀,可步行對生活不影響 187 (40.7) 536 (43.2)
2 躺在床上時間小於50% 22 ( 4.8) 83 ( 6.7)
3 躺在床上時間大於50% 3 ( 0.7) 9 ( 0.7)
4 完全臥床 0 ( 0.0) 4 ( 0.3)
性別 (%) 1 男 202 (42.2) 636 (41.2) 0.736 0.020
2 女 277 (57.8) 909 (58.8)
BMI (%) Normal 228 (63.2) 582 (62.2) 0.793 0.020
Overweight 133 (36.8) 354 (37.8)
Cell_Type (%) 1 urothelial 414 (86.4) 1390 (90.0) 0.090 0.111
5 UC with variants (Squamous cell, glandular, sarcomatous, micro papillary, neuroendocrine, lymphoepithelial) 61 (12.7) 147 ( 9.5)
6 others 4 ( 0.8) 8 ( 0.5)
左右側 (%) 1 左 249 (52.0) 802 (51.9) 0.990 0.008
2 右 223 (46.6) 719 (46.5)
3 雙側 7 ( 1.5) 24 ( 1.6)
腫瘤位置 (%) 0 non-visible 1 ( 0.2) 1 ( 0.1) 0.517 0.104
1 腎盂 186 (38.8) 655 (42.4)
2 輸尿管 175 (36.5) 500 (32.4)
3 膀胱袖口 1 ( 0.2) 2 ( 0.1)
4 多個位置 115 (24.0) 385 (24.9)
5 無法識別 1 ( 0.2) 2 ( 0.1)
多發性 (%) 0 Not available 19 ( 4.0) 92 ( 6.0) 0.246 0.092
1 No 295 (61.6) 936 (60.6)
2 Yes 165 (34.4) 517 (33.5)
腫瘤大小 (%) 0 Not available 7 ( 1.5) 56 ( 3.6) 0.050 0.141
1 <2cm 153 (31.9) 462 (29.9)
2 >=2cm 319 (66.6) 1027 (66.5)
病理分期 (%) 1 stage 0a/0is 73 (15.7) 241 (15.8) 0.028 0.168
2 stage I 118 (25.3) 436 (28.7)
3 stage II 79 (17.0) 296 (19.5)
4 stage III 144 (30.9) 442 (29.1)
5 stage IV 52 (11.2) 106 ( 7.0)
完整檢體腫瘤惡性度 (%) 1 papillary urothelial neoplasm of low malignant potential 1 ( 0.2) 1 ( 0.1) 0.497 0.082
2 low grade 47 (10.0) 140 ( 9.2)
3 high grade 418 (89.3) 1372 (89.8)
4 Gx 2 ( 0.4) 15 ( 1.0)
合併膀胱腫瘤 (%) 0 No 356 (75.3) 1078 (72.2) 0.519 0.081
1 Previous Hx of bladder UC 33 ( 7.0) 114 ( 7.6)
2 Concurrent Bladder UC 70 (14.8) 261 (17.5)
3 Not available 14 ( 3.0) 41 ( 2.7)
合併CIS (%) 0 No 323 (68.4) 1060 (71.0) 0.324 0.055
1 Yes 149 (31.6) 434 (29.0)
Lymphovascular_invasion (%) 0 No 366 (79.9) 1256 (82.5) 0.240 0.065
1 Yes 92 (20.1) 267 (17.5)
surgical_margin (%) 0 free 449 (94.5) 1472 (96.7) 0.050 0.104
1 positive 26 ( 5.5) 51 ( 3.3)
術前水腎 (%) 1 No 207 (44.5) 719 (48.6) 0.139 0.082
2 Yes 258 (55.5) 761 (51.4)
Tumor_Necrosis (%) 0 No 412 (87.8) 1133 (84.5) 0.090 0.097
1 Yes 57 (12.2) 208 (15.5)
有無針對UTUC化療 (%) 0 No 321 (67.0) 1075 (69.6) 0.018 0.155
1 Yes 148 (30.9) 404 (26.1)
2 Not available 10 ( 2.1) 66 ( 4.3)
針對UTUC化療型態 (%) 1 neo-adjuvant 20 (13.5) 42 (10.3) 0.029 0.273
2 adjuvant 92 (62.2) 297 (73.2)
3 salvage (curative intent) 13 ( 8.8) 15 ( 3.7)
4 palliative (S/S relieve) 23 (15.5) 52 (12.8)
化療處方 (%) 1 Gemcitabine & cisplatin 39 (27.3) 125 (31.6) 0.202 0.224
2 MVAC 10 ( 7.0) 11 ( 2.8)
3 Taxans-based 0 ( 0.0) 1 ( 0.3)
4 Carboplatin-based 49 (34.3) 141 (35.7)
5 others 45 (31.5) 117 (29.6)
Bladder_cuff_resection (%) 0 Not perform BCR 11 ( 2.5) 47 ( 3.3) <0.001 2.391
1 Open incision 92 (21.0) 1027 (71.3)
2 Transurethral incision 9 ( 2.1) 55 ( 3.8)
4 Laparoscopy 6 ( 1.4) 306 (21.2)
5 Robot assisted 321 (73.1) 5 ( 0.3)
simultaneously_ipsilateral_adrenalectomy (%) 0 No 408 (94.0) 1205 (92.7) 0.410 0.053
1 Yes 26 ( 6.0) 95 ( 7.3)
Post_operation_intravesical_CT_instillation (%) 1 No 356 (81.8) 1370 (96.0) <0.001 0.495
2 術中膀胱灌藥 41 ( 9.4) 6 ( 0.4)
3 術後膀胱灌藥 38 ( 8.7) 51 ( 3.6)
Clavien_Dindo_classification (%) 0 No Complication 284 (62.8) 905 (65.7) 0.318 0.155
1 Grade I 78 (17.3) 175 (12.7)
2 Grade II 76 (16.8) 239 (17.4)
3 Grade IIIa 4 ( 0.9) 14 ( 1.0)
4 Grade IIIb 4 ( 0.9) 21 ( 1.5)
5 Grade IVa 3 ( 0.7) 16 ( 1.2)
6 Grade IVb 0 ( 0.0) 1 ( 0.1)
7 Grade V 3 ( 0.7) 6 ( 0.4)
Disease_free (%) 0 No 107 (22.3) 258 (16.7) <0.001 0.238
1 Yes 317 (66.2) 1089 (70.5)
3 Segmental resection 後復發或轉移 11 ( 2.3) 6 ( 0.4)
4 Unknown 44 ( 9.2) 192 (12.4)
Mortality (%) 0 No 313 (65.3) 838 (54.2) <0.001 0.343
1 UTUC related 66 (13.8) 176 (11.4)
2 Non-UTUC related 44 ( 9.2) 232 (15.0)
3 死因不明 27 ( 5.6) 204 (13.2)
4 Surgery related 2 ( 0.4) 9 ( 0.6)
5 無法判斷生死 27 ( 5.6) 86 ( 5.6)
長期_Complication (%) ESRD 11 ( 2.4) 48 ( 3.3) 0.032 0.218
ESRD, ileus 0 ( 0.0) 3 ( 0.2)
ESRD, ureter stricture (手術患側) 0 ( 0.0) 1 ( 0.1)
ESRD, ventral hernia 1 ( 0.2) 1 ( 0.1)
ileus 6 ( 1.3) 12 ( 0.8)
ileus, ventral hernia 0 ( 0.0) 6 ( 0.4)
No Complication 426 (92.4) 1362 (93.4)
No Complication, ureter stricture (手術患側) 0 ( 0.0) 2 ( 0.1)
ureter stricture (手術患側) 13 ( 2.8) 11 ( 0.8)
ventral hernia 4 ( 0.9) 12 ( 0.8)
Lost_follow_up (%) 0 No 419 (89.3) 1386 (93.3) 0.007 0.140
1 Yes 50 (10.7) 100 ( 6.7)
術後住院天數_day (mean (SD)) 7.60 (4.16) 8.44 (5.67) 0.004 0.168
手術到死亡間隔時間_月 (mean (SD)) 24.10 (17.50) 38.73 (32.69) <0.001 0.558
Longest_follow_up_month_for_BDFS_DFS (mean (SD)) 31.35 (22.81) 39.23 (31.63) <0.001 0.286
診斷年紀 (mean (SD)) 69.29 (10.23) 68.74 (10.49) 0.309 0.054
性別參數 (mean (SD)) 0.58 (0.49) 0.59 (0.49) 0.757 0.016
術前eGFR_MDRD_ml_min_1_73m2 (mean (SD)) 59.81 (44.62) 55.12 (43.81) 0.042 0.106
Post_OP_1_month_eGFR (mean (SD)) 161.97 (98.04) 164.65 (97.89) 0.601 0.027

Original

Patient’s Baseline Characteristics
level 1 ROBOT 2 LPS+LESS p test SMD
n 482 1551
ECOG (%) 0 無症狀 251 (52.1) 612 (39.5) <0.001 0.522
1 有症狀,可步行對生活不影響 187 (38.8) 538 (34.7)
2 躺在床上時間小於50% 22 ( 4.6) 83 ( 5.4)
3 躺在床上時間大於50% 3 ( 0.6) 9 ( 0.6)
4 完全臥床 0 ( 0.0) 4 ( 0.3)
NA 19 ( 3.9) 305 (19.7)
性別 (%) 1 男 203 (42.1) 636 (41.0) 0.704 0.023
2 女 279 (57.9) 915 (59.0)
身高 (mean (SD)) 158.38 (8.36) 158.01 (8.49) 0.480 0.044
體重 (mean (SD)) 60.72 (11.61) 61.42 (22.53) 0.576 0.039
Cell_Type (%) 1 urothelial 414 (85.9) 1393 (89.8) 0.038 0.156
2 squamous 0 ( 0.0) 2 ( 0.1)
3 small cell 2 ( 0.4) 1 ( 0.1)
4 adenocarcinoma 1 ( 0.2) 0 ( 0.0)
5 UC with variants (Squamous cell, glandular, sarcomatous, micro papillary, neuroendocrine, lymphoepithelial) 61 (12.7) 147 ( 9.5)
6 others 4 ( 0.8) 8 ( 0.5)
左右側 (%) 1 左 251 (52.1) 805 (51.9) 0.953 0.037
2 右 224 (46.5) 721 (46.5)
3 雙側 7 ( 1.5) 24 ( 1.5)
NA 0 ( 0.0) 1 ( 0.1)
腫瘤位置_多選 (%) 0 non-visible 1 ( 0.2) 2 ( 0.1) 0.191 0.348
1 腎盂 187 (38.8) 656 (42.3)
1 腎盂, 2 上輸尿管 42 ( 8.7) 136 ( 8.8)
1 腎盂, 2 上輸尿管, 4 下輸尿管 0 ( 0.0) 9 ( 0.6)
1 腎盂, 2 上輸尿管, 4 下輸尿管, 5 膀胱袖口 0 ( 0.0) 2 ( 0.1)
1 腎盂, 2 上輸尿管, 5 膀胱袖口 0 ( 0.0) 2 ( 0.1)
1 腎盂, 4 下輸尿管 14 ( 2.9) 40 ( 2.6)
1 腎盂, 4 下輸尿管, 5 膀胱袖口 0 ( 0.0) 1 ( 0.1)
1 腎盂, 5 膀胱袖口 0 ( 0.0) 2 ( 0.1)
1 腎盂, 5 膀胱袖口, 6 Urerter, unknown site 1 ( 0.2) 0 ( 0.0)
1 腎盂, 6 Urerter, unknown site 10 ( 2.1) 12 ( 0.8)
2 上輸尿管 70 (14.5) 166 (10.7)
2 上輸尿管, 4 下輸尿管 3 ( 0.6) 10 ( 0.6)
2 上輸尿管, 4 下輸尿管, 5 膀胱袖口 0 ( 0.0) 1 ( 0.1)
2 上輸尿管, 5 膀胱袖口 0 ( 0.0) 2 ( 0.1)
2 上輸尿管, 6 Urerter, unknown site 0 ( 0.0) 1 ( 0.1)
3 中輸尿管 46 ( 9.5) 136 ( 8.8)
3 中輸尿管, 1 腎盂 5 ( 1.0) 28 ( 1.8)
3 中輸尿管, 1 腎盂, 2 上輸尿管 6 ( 1.2) 14 ( 0.9)
3 中輸尿管, 1 腎盂, 2 上輸尿管, 4 下輸尿管 5 ( 1.0) 20 ( 1.3)
3 中輸尿管, 1 腎盂, 2 上輸尿管, 4 下輸尿管, 5 膀胱袖口 2 ( 0.4) 1 ( 0.1)
3 中輸尿管, 1 腎盂, 4 下輸尿管 6 ( 1.2) 12 ( 0.8)
3 中輸尿管, 1 腎盂, 4 下輸尿管, 5 膀胱袖口 1 ( 0.2) 0 ( 0.0)
3 中輸尿管, 1 腎盂, 5 膀胱袖口 0 ( 0.0) 3 ( 0.2)
3 中輸尿管, 2 上輸尿管 9 ( 1.9) 23 ( 1.5)
3 中輸尿管, 2 上輸尿管, 4 下輸尿管 0 ( 0.0) 19 ( 1.2)
3 中輸尿管, 2 上輸尿管, 4 下輸尿管, 5 膀胱袖口 0 ( 0.0) 1 ( 0.1)
3 中輸尿管, 4 下輸尿管 7 ( 1.5) 31 ( 2.0)
3 中輸尿管, 4 下輸尿管, 5 膀胱袖口 1 ( 0.2) 1 ( 0.1)
3 中輸尿管, 5 膀胱袖口 0 ( 0.0) 4 ( 0.3)
4 下輸尿管 56 (11.6) 187 (12.1)
4 下輸尿管, 5 膀胱袖口 3 ( 0.6) 11 ( 0.7)
5 膀胱袖口 1 ( 0.2) 2 ( 0.1)
6 Urerter, unknown site 5 ( 1.0) 14 ( 0.9)
7 Not available 1 ( 0.2) 1 ( 0.1)
NA 0 ( 0.0) 1 ( 0.1)
多發性 (%) 0 Not available 10 ( 2.1) 30 ( 1.9) 0.174 0.127
1 No 298 (61.8) 939 (60.5)
2 Yes 165 (34.2) 520 (33.5)
NA 9 ( 1.9) 62 ( 4.0)
腫瘤大小 (%) 0 non-visible 6 ( 1.2) 24 ( 1.5) 0.030 0.233
1 &#60;1cm 26 ( 5.4) 49 ( 3.2)
1 <1cm 13 ( 2.7) 74 ( 4.8)
2 ≥1 & &#60; 2 cm 40 ( 8.3) 134 ( 8.6)
2 ≥1 & < 2 cm 68 (14.1) 182 (11.7)
3 ≥2 & &#60; 3 cm 40 ( 8.3) 152 ( 9.8)
3 ≥2 & < 3 cm 77 (16.0) 215 (13.9)
4 ≥ 3cm 205 (42.5) 665 (42.9)
Not available 4 ( 0.8) 39 ( 2.5)
NA 3 ( 0.6) 17 ( 1.1)
病理分期 (%) 1 stage 0a 68 (14.1) 210 (13.5) 0.015 0.203
2 stage 0is 5 ( 1.0) 31 ( 2.0)
3 stage I 118 (24.5) 438 (28.2)
4 stage II 79 (16.4) 296 (19.1)
5 stage III 146 (30.3) 444 (28.6)
6 stage IV 53 (11.0) 107 ( 6.9)
NA 13 ( 2.7) 25 ( 1.6)
完整檢體腫瘤惡性度 (%) 1 papillary urothelial neoplasm of low malignant potential 1 ( 0.2) 1 ( 0.1) <0.001 0.325
2 low grade 47 ( 9.8) 140 ( 9.0)
3 high grade 416 (86.3) 1290 (83.2)
4 Gx 4 ( 0.8) 15 ( 1.0)
6 G2 2 ( 0.4) 86 ( 5.5)
8 Well differentiated 0 ( 0.0) 1 ( 0.1)
NA 12 ( 2.5) 18 ( 1.2)
合併膀胱腫瘤 (%) 0 No 359 (74.5) 1083 (69.8) 0.088 0.161
1 Previous Hx of bladder UC 33 ( 6.8) 114 ( 7.4)
2 Concurrent Bladder UC 70 (14.5) 262 (16.9)
3 Not available 14 ( 2.9) 41 ( 2.6)
NA 6 ( 1.2) 51 ( 3.3)
合併CIS (%) 0 No 326 (67.6) 1064 (68.6) 0.058 0.134
1 Yes 149 (30.9) 435 (28.0)
NA 7 ( 1.5) 52 ( 3.4)
Lymphovascular_invasion (%) 0 No 368 (76.3) 1261 (81.3) <0.001 0.196
1 Yes 92 (19.1) 268 (17.3)
NA 22 ( 4.6) 22 ( 1.4)
surgical_margin (%) 0 free 451 (93.6) 1475 (95.1) 0.044 0.126
1 positive 27 ( 5.6) 52 ( 3.4)
NA 4 ( 0.8) 24 ( 1.5)
術前水腎 (%) 1 No 208 (43.2) 722 (46.6) 0.129 0.107
2 Yes 260 (53.9) 764 (49.3)
NA 14 ( 2.9) 65 ( 4.2)
Tumor_Necrosis (%) 0 No 414 (85.9) 1138 (73.4) <0.001 0.439
1 Yes 58 (12.0) 208 (13.4)
NA 10 ( 2.1) 205 (13.2)
有無針對UTUC化療 (%) 0 No 322 (66.8) 1078 (69.5) 0.028 0.172
1 Yes 150 (31.1) 407 (26.2)
2 Not available 0 ( 0.0) 8 ( 0.5)
NA 10 ( 2.1) 58 ( 3.7)
針對UTUC化療型態 (%) 1 neo-adjuvant 20 ( 4.1) 42 ( 2.7) 0.008 0.176
2 adjuvant 94 (19.5) 299 (19.3)
3 salvage (curative intent) 13 ( 2.7) 15 ( 1.0)
4 palliative (S/S relieve) 23 ( 4.8) 52 ( 3.4)
NA 332 (68.9) 1143 (73.7)
化療處方 (%) 1 Gemcitabine & cisplatin 39 ( 8.1) 125 ( 8.1) 0.066 0.154
2 MVAC 10 ( 2.1) 11 ( 0.7)
3 Taxans-based 0 ( 0.0) 1 ( 0.1)
4 Carboplatin-based 49 (10.2) 141 ( 9.1)
5 others 47 ( 9.8) 119 ( 7.7)
NA 337 (69.9) 1154 (74.4)
Bladder_cuff_resection (%) 0 Not perform BCR 11 ( 2.3) 47 ( 3.0) <0.001 2.177
1 Open incision 94 (19.5) 1030 (66.4)
2 Transurethral incision 9 ( 1.9) 56 ( 3.6)
4 Laparoscopy 6 ( 1.2) 302 (19.5)
5 Robot assisted 321 (66.6) 5 ( 0.3)
6 LESS 0 ( 0.0) 5 ( 0.3)
NA 41 ( 8.5) 106 ( 6.8)
simultaneously_ipsilateral_adrenalectomy (%) 0 no 410 (85.1) 1210 (78.0) 0.002 0.197
1 yes 26 ( 5.4) 95 ( 6.1)
NA 46 ( 9.5) 246 (15.9)
Post_operation_intravesical_CT_instillation (%) 1 No 356 (73.9) 1367 (88.1) <0.001 0.496
1 No, 7 術中膀胱灌藥-Mitomycin C 1 ( 0.2) 0 ( 0.0)
10 Yes, Epirubicin 3 ( 0.6) 8 ( 0.5)
2 Yes, Mitomycin C 18 ( 3.7) 35 ( 2.3)
3 Yes, Doxorubicin 19 ( 3.9) 13 ( 0.8)
3 Yes, Doxorubicin, 6 Yes, Cisplatin 0 ( 0.0) 1 ( 0.1)
5 Yes, BCG 1 ( 0.2) 2 ( 0.1)
5 Yes, BCG, 10 Yes, Epirubicin 0 ( 0.0) 1 ( 0.1)
7 術中膀胱灌藥-Mitomycin C 10 ( 2.1) 2 ( 0.1)
8 術中膀胱灌藥-Epirubicin 30 ( 6.2) 3 ( 0.2)
9 術中膀胱灌藥-Gemcitabine 0 ( 0.0) 1 ( 0.1)
NA 44 ( 9.1) 118 ( 7.6)
Clavien_Dindo_classification_複選 (%) 0 No Complication 285 (59.1) 910 (58.7) 0.115 0.289
1 Grade I: 79 (16.4) 175 (11.3)
1 Grade I:, 2 Grade II: 11 ( 2.3) 20 ( 1.3)
1 Grade I:, 2 Grade II:, 4        - IIIb 0 ( 0.0) 1 ( 0.1)
1 Grade I:, 2 Grade II:, 4        - IIIb, 5 Grade - IVa, 7 Greade V 1 ( 0.2) 0 ( 0.0)
1 Grade I:, 2 Grade II:, 5 Grade - IVa 0 ( 0.0) 1 ( 0.1)
1 Grade I:, 2 Grade II:, 7 Greade V 0 ( 0.0) 2 ( 0.1)
1 Grade I:, 4        - IIIb 0 ( 0.0) 1 ( 0.1)
1 Grade I:, 4        - IIIb, 6        - IVb, 7 Greade V 0 ( 0.0) 1 ( 0.1)
1 Grade I:, 5 Grade - IVa 0 ( 0.0) 1 ( 0.1)
2 Grade II: 65 (13.5) 219 (14.1)
2 Grade II:, 3 Grade - IIIa: 1 ( 0.2) 5 ( 0.3)
2 Grade II:, 4        - IIIb 1 ( 0.2) 5 ( 0.3)
2 Grade II:, 4        - IIIb, 3 Grade - IIIa: 0 ( 0.0) 1 ( 0.1)
2 Grade II:, 4        - IIIb, 7 Greade V, 3 Grade - IIIa: 0 ( 0.0) 1 ( 0.1)
2 Grade II:, 5 Grade - IVa 1 ( 0.2) 4 ( 0.3)
2 Grade II:, 6        - IVb, 7 Greade V, 3 Grade - IIIa: 0 ( 0.0) 1 ( 0.1)
2 Grade II:, 7 Greade V 1 ( 0.2) 0 ( 0.0)
3 Grade - IIIa: 3 ( 0.6) 10 ( 0.6)
4        - IIIb 3 ( 0.6) 13 ( 0.8)
5 Grade - IVa 2 ( 0.4) 10 ( 0.6)
6        - IVb 0 ( 0.0) 1 ( 0.1)
6        - IVb, 7 Greade V 1 ( 0.2) 1 ( 0.1)
NA 28 ( 5.8) 168 (10.8)
Disease_free (%) 0 No (NxUx) 1 ( 0.2) 3 ( 0.2) <0.001 0.262
0 NUx 後復發或轉移 106 (22.0) 255 (16.4)
1 Yes 6 ( 1.2) 31 ( 2.0)
1 Yes,沒有復發或轉移 313 (64.9) 1063 (68.5)
3 Segmental resection 後復發或轉移 12 ( 2.5) 7 ( 0.5)
4 Unknown 0 ( 0.0) 3 ( 0.2)
4 不知道 35 ( 7.3) 132 ( 8.5)
NA 9 ( 1.9) 57 ( 3.7)
Mortality (%) 0 no 315 (65.4) 843 (54.4) <0.001 0.408
1 UTUC related 67 (13.9) 176 (11.3)
2 non-UTUC related 44 ( 9.1) 232 (15.0)
3 Nonknown 18 ( 3.7) 179 (11.5)
3 死因不明 9 ( 1.9) 26 ( 1.7)
4 Surgery related 2 ( 0.4) 9 ( 0.6)
5 無法判斷生死 18 ( 3.7) 28 ( 1.8)
NA 9 ( 1.9) 58 ( 3.7)
長期_Complication (%) ESRD 11 ( 2.3) 48 ( 3.1) 0.020 0.231
ESRD, ileus 0 ( 0.0) 3 ( 0.2)
ESRD, ureter stricture (手術患側) 0 ( 0.0) 1 ( 0.1)
ESRD, ventral hernia 1 ( 0.2) 1 ( 0.1)
ileus 6 ( 1.2) 12 ( 0.8)
ileus, ventral hernia 0 ( 0.0) 6 ( 0.4)
No Complication 429 (89.0) 1368 (88.2)
No Complication, ureter stricture (手術患側) 0 ( 0.0) 2 ( 0.1)
ureter stricture (手術患側) 13 ( 2.7) 11 ( 0.7)
ventral hernia 4 ( 0.8) 12 ( 0.8)
NA 18 ( 3.7) 87 ( 5.6)
Lost_follow_up (%) 0 No 422 (87.6) 1392 (89.7) 0.004 0.171
1 Yes 50 (10.4) 100 ( 6.4)
NA 10 ( 2.1) 59 ( 3.8)
術後住院天數_day (mean (SD)) 7.59 (4.15) 8.43 (5.66) 0.004 0.169
手術到死亡間隔時間_月 (mean (SD)) 23.98 (17.47) 40691.78 (824169.30) 0.585 0.070
Longest_follow_up_month_for_BDFS_DFS (mean (SD)) 31.50 (22.99) 39.26 (31.61) <0.001 0.281
診斷年紀 (mean (SD)) 69.33 (10.23) 68.71 (10.50) 0.253 0.060
性別參數 (mean (SD)) 0.58 (0.49) 0.59 (0.49) 0.725 0.018
術前eGFR_MDRD_ml_min_1_73m2 (mean (SD)) Inf (NaN) Inf (NaN) NaN NaN
Post_OP_1_month_eGFR (mean (SD)) Inf (NaN) Inf (NaN) NaN NaN

2 Missing Value

missingValue.Table(RobotLPS2)
matrixplot_missing(RobotLPS2)